cber
Entity, reached from Hormuz.
- Evidence
- 36 documents · 4 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 14 Apr 2026, last seen 9 Oct 2026
- Measured
- 42% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- FDA · 2026-09-30 · Study Data Standards Resources (opens the source in a new tab)
- FDA · 2026-09-18 · CDER Data Standards Program (opens the source in a new tab)
- FDA · 2026-09-17 · Recently Issued Guidance Documents (opens the source in a new tab)
- FDA · 2026-09-11 · FDA Rare Disease Innovation Hub (opens the source in a new tab)
- STAT News · 2026-09-10 · STAT+: Orexin discoverers awarded prestigious Lasker award (opens the source in a new tab)
- FDA Drug News · 2026-06-13 · [APPROVAL] Real-World Evidence Submissions to the Center for Biologics Evaluation and Research & the Center for Drug Evaluation and Research (opens the source in a new tab)
- FDA Drug News · 2026-04-17 · Electronic Submission of Adverse Event Reports to FDA Adverse Event Reporting System (FAERS) using International Council for Harmonisation (ICH) E2B(R3) Standards - 04/04… (opens the source in a new tab)
Links from here: not yet read.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (36 documents)seen together
- co-mentioned with cder (30 documents)seen together
- co-mentioned with drug evaluation (21 documents)seen together
- co-mentioned with biologics evaluation (20 documents)seen together
- co-mentioned with drug development (15 documents)seen together
- co-mentioned with biological products (13 documents)seen together
- co-mentioned with drug administration (13 documents)seen together
- co-mentioned with investigational new drug (12 documents)seen together
- co-mentioned with clinical trial (11 documents)seen together
- co-mentioned with cdrh (9 documents)seen together